Page
| ||
Financial Statements
| ||
Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021
|
1
| |
Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021
|
2
| |
Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2022 and 2021
|
3
| |
Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021
|
4
| |
Notes to Consolidated Financial Statements
|
5
|
March 31, 2022
|
December 31, 2021
|
* | ||||||
(Unaudited)
| ||||||||
(In thousands except share data)
| ||||||||
ASSETS
| ||||||||
Assets
| ||||||||
Current assets:
| ||||||||
Cash and cash equivalents
|
$
|
6,761
|
$
|
2,227
| ||||
Accounts receivable, net
|
2,645
|
3,045
| ||||||
Contract assets
|
303
|
364
| ||||||
Prepaid expenses and other current assets
|
1,297
|
843
| ||||||
Total current assets
|
11,006
|
6,479
| ||||||
Property and equipment, net
|
495
|
480
| ||||||
Deposits
|
84
|
84
| ||||||
Total assets
|
$
|
11,585
|
$
|
7,043
| ||||
LIABILITIES AND STOCKHOLDERS' EQUITY
| ||||||||
Liabilities
| ||||||||
Current liabilities:
| ||||||||
Accounts payable
|
$
|
580
|
$
|
412
| ||||
Related party payable
|
33
|
5
| ||||||
Accrued wages and commissions
|
691
|
805
| ||||||
Accrued expenses
|
888
|
855
| ||||||
Other liabilities
|
39
|
57
| ||||||
Interest payable - 15% convertible promissory note
|
89
|
-
| ||||||
Notes payable - 15% convertible promissory note
|
7,000
|
-
| ||||||
Contract liabilities
|
485
|
450
| ||||||
Total liabilities
|
$
|
9,805
|
$
|
2,584
| ||||
Commitments and Contingencies
| ||||||||
Stockholders' Equity
| ||||||||
Series B Preferred (par value $0.001 per shares, 4,584,202 authorized, issued and outstanding at March 31, 2022 and December 31, 2021)
|
$
|
5
|
$
|
5
| ||||
Series A Preferred (par value $0.001 per shares, 5,088,944 authorized issued and outstanding at March 31, 2022 and December 31, 2021)
|
5
|
5
| ||||||
Series Seed Preferred (par value $0.001 per shares, 6,911,715 authorized issued and outstanding at March 31, 2022 and December 31, 2021)
|
7
|
7
| ||||||
Common stock (par value $0.001 per shares, 38,395,870 authorized at March 31, 2022 and 2021; 13,576,115 and 13,540,824 issued and outstanding as of March 31, 2022 and December 31, 2021)
|
14
|
14
| ||||||
Additional paid-in-capital
|
17,840
|
17,653
| ||||||
Accumulated deficit
|
(16,091
|
)
|
(13,225
|
)
| ||||
Total stockholders' equity
|
1,780
|
4,459
| ||||||
Total liabilities and stockholders' equity
|
$
|
11,585
|
$
|
7,043
|
2022
|
2021
| |||||||
(In thousands, except share and per share data)
| ||||||||
Revenues
|
$
|
6,364
|
$
|
5,209
| ||||
Cost of revenues
|
1,843
|
1,594
| ||||||
Gross profit
|
4,521
|
3,615
| ||||||
Operating expenses
| ||||||||
Selling, servicing and marketing
|
2,943
|
2,071
| ||||||
Technology and software development
|
2,637
|
1,551
| ||||||
General and administrative
|
1,718
|
1,112
| ||||||
7,298
|
4,734
| |||||||
Loss from operations
|
(2,777
|
)
|
(1,119
|
)
| ||||
Interest income
|
-
|
1
| ||||||
Interest expense
|
(89
|
)
|
-
| |||||
Loss before provision for income taxes
|
(2,866
|
)
|
(1,118
|
)
| ||||
Provision for income taxes
|
-
|
-
| ||||||
Net loss
|
$
|
(2,866
|
)
|
$
|
(1,118
|
)
| ||
Net loss per common share:
| ||||||||
Basic and diluted
|
$
|
(0.21
|
)
|
$
|
(0.08
|
)
| ||
Weighted-average common shares outstanding - basic and diluted
|
13,571,872
|
13,319,512
|
Series B Preferred
|
Series A Preferred
|
Series Seed
Preferred
|
Common Stock
|
Additional Paid-in- Capital
|
Accumulated Deficit
|
Total
| ||||||||||||||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
| |||||||||||||||||||||||||||||||||||||
(In thousands )
| ||||||||||||||||||||||||||||||||||||||||||||
Balance - January 1, 2021
|
4,584
|
$
|
5
|
5,089
|
$
|
5
|
6,912
|
$
|
7
|
13,200
|
$
|
14
|
$
|
16,970
|
$
|
(7,475
|
)
|
$
|
9,526
| |||||||||||||||||||||||||
Stock-based compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
114
|
-
|
119
|
-
|
119
| |||||||||||||||||||||||||||||||||
Issuance of common stock
|
-
|
-
|
-
|
-
|
-
|
-
|
67
|
-
|
50
|
-
|
50
| |||||||||||||||||||||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,118
|
)
|
(1,118
|
)
| |||||||||||||||||||||||||||||||
Balance - March 31, 2021
|
4,584
|
$
|
5
|
5,089
|
$
|
5
|
6,912
|
$
|
7
|
13,381
|
$
|
14
|
$
|
17,139
|
$
|
(8,593
|
)
|
$
|
8,577
| |||||||||||||||||||||||||
Balance - January 1, 2022
|
4,584
|
5
|
5,089
|
$
|
5
|
6,912
|
$
|
7
|
13,541
|
$
|
14
|
$
|
17,653
|
$
|
(13,225
|
)
|
$
|
4,459
| ||||||||||||||||||||||||||
Stock-based compensation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
181
|
-
|
181
| |||||||||||||||||||||||||||||||||
Exercise of stock options
|
-
|
-
|
-
|
-
|
-
|
-
|
35
|
-
|
6
|
-
|
6
| |||||||||||||||||||||||||||||||||
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,866
|
)
|
(2,866
|
)
| |||||||||||||||||||||||||||||||
Balance - March 31, 2022
|
4,584
|
$
|
5
|
5,089
|
$
|
5
|
6,912
|
$
|
7
|
13,576
|
$
|
14
|
$
|
17,840
|
$
|
(16,091
|
)
|
$
|
1,780
| |||||||||||||||||||||||||
For The Three Months
Ended March 31,
| ||||||||
2022
|
2021
| |||||||
( In thousands)
| ||||||||
Cash flows from operating activities:
| ||||||||
Net loss
|
$
|
(2,866
|
)
|
$
|
(1,118
|
)
| ||
Adjustments to reconcile net loss to net cash used in operating activities:
| ||||||||
Depreciation and amortization
|
59
|
6
| ||||||
Stock-based compensation expense
|
181
|
119
| ||||||
Changes in operating assets and liabilities:
| ||||||||
Accounts receivable
|
400
|
(110
|
)
| |||||
Related party receivable
|
-
|
77
| ||||||
Prepaid expenses and other current assets
|
(453
|
)
|
(84
|
)
| ||||
Contract assets
|
61
|
(8
|
)
| |||||
Accounts payable and other liabilities
|
67
|
(27
|
)
| |||||
Related party payable
|
28
|
(56
|
)
| |||||
Interest payable - 15% convertible promissory note
|
89
|
-
| ||||||
Contract liabilities
|
35
|
50
| ||||||
Net cash used in operating activities
|
(2,399
|
)
|
(1,151
|
)
| ||||
Cash flows from investing activities:
| ||||||||
Business combination, net of cash acquired
|
-
|
(122
|
)
| |||||
Purchases of property and equipment
|
(73
|
)
|
(42
|
)
| ||||
Net cash used in investing activities
|
(73
|
)
|
(164
|
)
| ||||
Cash flows from financing activities:
| ||||||||
Notes payable - 15% convertible promissory note
|
7,000
|
-
| ||||||
Proceeds from exercise of stock options, net
|
6
|
-
| ||||||
Net cash provided by financing activities
|
7,006
|
-
| ||||||
Net increase (decrease) in cash and cash equivalents
|
4,534
|
(1,315
|
)
| |||||
Cash and cash equivalents at beginning of the period
|
2,227
|
10,447
| ||||||
Cash and cash equivalents at end of the period
|
$
|
6,761
|
$
|
9,132
| ||||
Supplemental disclosure of non-cash financing activities
| ||||||||
Issue of common stock for business combination
|
$
|
-
|
$
|
50
| ||||
Indemnity holdback for business combination
|
$
|
-
|
$
|
23
|
March 31,
|
December 31
| |||||||
2022
|
2021
| |||||||
Accounts receivable
|
$
|
2,093
|
$
|
2,533
| ||||
Unbilled receivables
|
849
|
809
| ||||||
2,942
|
3,342
| |||||||
Less allowance for doubtful accounts
|
(297
|
)
|
(297
|
)
| ||||
Accounts receivable, net
|
$
|
2,645
|
$
|
3,045
|
March 31,
|
December 31
| |||||||
2022
|
2021
| |||||||
Computer equipment
|
$
|
268
|
$
|
225
| ||||
Data warehouse
|
286
|
256
| ||||||
Software
|
196
|
196
| ||||||
750
|
677
| |||||||
Less accumulated depreciation and amortization
|
(255
|
)
|
(197
|
)
| ||||
Property and Equipment
|
$
|
495
|
$
|
480
|
a. |
If the closing of the merger contemplated by the Agreement and Plan of Merger, dated as of November 8, 2021 as amended through by and among the Company, TCAC and the other parties thereto, occurs on or prior to the Maturity Date, then (i) the outstanding principal balance of the Convertible Notes shall become due and payable (and will be satisfied by the issuance to Holder of all shares of common stock at a rate of $10.00 per share; and (ii) all accrued and unpaid interest under the Convertible Notes shall become due and payable and shall be satisfied by dividing the outstanding unpaid accrued interest of the Convertible Notes, by $10.00.
|
b. |
If the SPAC Merger has not occurred on or prior to the Maturity Date, then, subject to Section 3(c), the outstanding principal balance and any unpaid accrued interest of the Convertible Notes shall automatically convert, without any further action by the Holder, into a number of fully paid and non-assessable shares of Series B Preferred Stock of the Company at $2.508067 per share, with such shares of Series B Preferred Stock to be issued pursuant to the Company's Amended and Restated Certificate of Incorporation and otherwise on the same terms and conditions as given to the investors in that certain Series B Stock Purchase Agreement dated as of August 7, 2020, as amended (the "Series B Purchase Agreement").
|
c. |
If the Company issues any additional equity securities on or prior to the Maturity Date and conversion of the Convertible Notes ("Other Securities"), then Holder shall have the option, in lieu of conversion pursuant to Section 3(b), to convert the outstanding principal balance and any unpaid accrued interest of the Convertible Notes into a number of fully paid and non-assessable shares of such Other Securities of the Company, equal to the per share price of such Other Securities.
|
March 31
| ||||||||
2022
|
2021
| |||||||
Revenue
| ||||||||
Brand revenue
|
$
|
189
|
$
|
132
| ||||
Retail revenue
|
6,175
|
5,077
| ||||||
Total Revenue
|
$
|
6,364
|
$
|
5,209
|
March 31
| ||||||||
2022
|
2021
| |||||||
Retail revenue
| ||||||||
United States
|
$
|
5,956
|
$
|
5,077
| ||||
Canada
|
219
|
-
| ||||||
Brand revenue
| ||||||||
United States
|
189
|
132
| ||||||
$
|
6,364
|
$
|
5,209
|
March 31
2022
|
December 31
2021
| |||||||
Contract assets consisted of the following as of:
| ||||||||
Deferred sales commissions
|
$
|
303
|
$
|
364
|
March 31
2022
|
December 31
2021
| |||||||
Contract liabilities consisted of the following as of:
| ||||||||
Deferred revenue retail
|
$
|
231
|
$
|
231
| ||||
Deferred set-up revenues
|
110
|
101
| ||||||
Deferred revenue brands
|
143
|
118
| ||||||
Contract liabilities
|
$
|
484
|
$
|
450
|
March 31
2022
|
December 31
2021
| |||||||
The movement in the contract liabilities during each period comprised the following:
| ||||||||
Contract liabilities at start of the period
|
$
|
450
|
$
|
560
| ||||
Amounts invoiced during the period
|
6,114
|
13,512
| ||||||
Less revenue recognized during the period
|
(6,080
|
)
|
(13,622
|
)
| ||||
Contract liabilities at end of the period
|
$
|
484
|
$
|
450
|
March 31, 2021
| ||||
Fair value of shares
|
$
|
135
| ||
Less: Post combination cost - restricted stocks
|
(85
|
)
| ||
Fair value of net shares
|
50
| |||
Cash consideration
|
132
| |||
Indemnity holdback
|
23
| |||
Fair value of purchase consideration
|
$
|
205
| ||
Assets
|
$
|
9
| ||
Goodwill
|
-
| |||
Intangibles (Software)
|
196
| |||
Fair value of assets
|
$
|
205
|
Options Outstanding
|
Options Vested and Exercisable
| |||||||||||||||||||
Fixed Options
|
Number of Options
|
Weighted
Average
Exercise Price
(Per Share)
|
Number of Options
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
Weighted
Average
Exercise
Price (Per
Share)
| |||||||||||||||
Outstanding Balance, January 1, 2022
|
6,802,437
|
$
|
0.38
|
4,628,311
|
6.79
|
$
|
0.24
| |||||||||||||
Options granted
|
-
|
$
|
-
| |||||||||||||||||
Options exercised
|
(34,791
|
)
|
$
|
0.19
| ||||||||||||||||
Options forfeited
|
(18,334
|
)
|
$
|
0.75
| ||||||||||||||||
Options cancelled
|
-
|
$
|
-
| |||||||||||||||||
Outstanding Balance, March 31, 2022
|
6,749,312
|
$
|
0.38
|
4,814,604
|
6.64
|
$
|
0.25
|
March 31
| ||||||||
2022
|
2021
| |||||||
Loss per share:
| ||||||||
Numerator:
| ||||||||
Net loss
|
$
|
(2,866
|
)
|
$
|
(1,118
|
)
| ||
Denominator
| ||||||||
Weighted-average common shares outstanding - basic and diluted
|
13,571,872
|
13,319,512
| ||||||
Basic and diluted loss per common share
|
$
|
(0.21
|
)
|
$
|
(0.08
|
)
|
March 31
| ||||||||
2022
|
2021
| |||||||
Shares subject to Series A Preferred Stock Conversion
|
5,088,944
|
5,088,944
| ||||||
Shares subject to Series B Preferred Stock Conversion
|
4,584,202
|
4,584,202
| ||||||
Shares subject to Seed Preferred Stock Conversion
|
6,911,715
|
6,911,715
| ||||||
Shares subject to 15% Convertible Promissory Notes Conversion
|
708,918
|
-
| ||||||
Shares vested and subject to exercise of stock options
|
4,814,604
|
4,020,032
| ||||||
Shares unvested and subject to exercise of stock options
|
1,934,708
|
2,099,238
|
March 31
2022
|
December 31
2021
| |||||||
Deferred tax assets:
| ||||||||
Accrued expenses and other liabilities
|
$
|
76
|
$
|
76
| ||||
Property and equipment, net
|
-
| |||||||
Net operating loss
|
4,115
|
3,402
| ||||||
Stock based compensation
|
147
|
132
| ||||||
Total gross deferred tax assets
|
4,338
|
3,610
| ||||||
Less: valuation allowance
|
(4,050
|
)
|
(3,385
|
)
| ||||
Total deferred tax assets
|
288
|
225
| ||||||
Deferred tax liabilities:
| ||||||||
Prepaid expenses and other assets
|
(214
|
)
|
(191.00
|
)
| ||||
Property and equipment, net
|
(74
|
)
|
(34.00
|
)
| ||||
Total deferred tax liabilities
|
(288
|
)
|
(225
|
)
| ||||
Net deferred income tax asset (liability)
|
$
|
-
|
$
|
-
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Tuatara Capital Acquisition Corporation published this content on 21 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 June 2022 10:13:29 UTC.